Camber Pharmaceuticals adds 100 count to Generic Neurontin®
Piscataway, NJ, June 6, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Gabapentin 100 count to its product line.
Last October, Camber launched Gabapentin Capsules 100, 300 and 400 mg in 500 count bottles.
Gabapentin Capsules, USP are available in a 100, 300 and 400 mg in 100 and 500 count bottles.
To learn more about Gabapentin Capsules, USP, please visit https://www.camberpharma.com/gabapentincapsules
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






